Imagion Announces Positive Results from IBI10103 Phase I Stu

/PRNewswire/ -- Imagion Biosystems Limited (ASX: IBX) recently announced positive results following completion of the IBI10103 phase I clinical trial...

Related Keywords

Melbourne , Victoria , Australia , California , United States , San Antonio , Texas , San Diego , Australian , Imagion Biosystems , Imagion Biosystem Magsense , Geoff Hollis , Disclosure Committee Of Imagion Biosystems , Prnewswire Imagion Biosystems Limited , Kbiosystems Limited , Isaac Bright , Managing Director , San Antonio Breast Cancer Symposium , Investigational New Drug , Noninvasive Detection , Lymph Node Involvement , Human Epidermal Growth Factor Receptor , Breast Cancer , First In Human Phasei Study , San Antonio Breast Cancer , Biosystem Magsense , Disclosure Committee , Investor Relations , Biotechnology , Health Care Amp Hospitals , Medical Pharmaceuticals , Medical Equipment , Broadcast Feed Annoucement , Clinical Trials Amp Medical Discoveries , Trade Show News ,